Blog
RSS FeedPosted by Michael Wonder on 26 Aug 2021
AbbVie receives a positive reimbursement recommendation from the Canadian Agencies for Drugs and Technology in Health (CADTH) pan-Canadian Oncology Drug Review Expert Review Committee (pERC) for Venclexta (venetoclax) in combination with azacitidine for acute myeloid leukaemia patients
26 August 2021 - pERC recommends reimbursement of Venclexta (venetoclax) in combination with azacitidine for the treatment of newly diagnosed acute ...
Posted by Michael Wonder on 31 May 2021
Roche Canada announces collaboration to improve access to personalised health care with real world evidence
28 May 2021 - BC Cancer, CPHIN and Roche Canada will co-create an evidence-generating framework to leverage real-world data and facilitate ...
Posted by Michael Wonder on 23 May 2021
'I would be able to live into my thirties:' Nova Scotia woman has high hopes for new cancer treatment
21 May 2021 - Maria Stevens was diagnosed with cervical cancer two years ago. Now, with a new treatment on ...
Posted by Michael Wonder on 06 May 2021
Coverage of oncology medicines well aligned across Canadian provinces, but sources of funding differ
4 May 2021 - The Patented Medicine Prices Review Board, through the National Prescription Drug Utilisation Information System research initiative, today ...
Posted by Michael Wonder on 04 May 2021
GSK’s Zejula is recommended for reimbursement by CADTH and INESSS for advanced ovarian cancer following response to first-line platinum-based chemotherapy
4 May 2021 - Zejula (niraparib) has received conditional positive recommendations for reimbursement from the Canadian Agency of Drugs and Technology ...
Posted by Michael Wonder on 29 Apr 2021
Bavencio receives reimbursement recommendation from pCODR and INESSS for the maintenance treatment of patients with advanced bladder cancer
29 April 2021 - EMD Serono Canada and Pfizer Canada are pleased to announce that Bavencio (avelumab for injection) has received ...
Posted by Michael Wonder on 26 Apr 2021
Kite's Yescarta (axicabtagene ciloleucel) reimbursed in Alberta for the treatment of certain types of aggressive non-Hodgkin lymphoma
23 April 2021 - Gilead Canada announced today that Yescarta (axicabtagene ciloleucel) is now available in Alberta as a treatment ...
Posted by Michael Wonder on 13 Jan 2021
CADTH publishes initial recommendation for nivolumab for NSCLC
9 January 2021 - The pERC has conditionally recommended the reimbursement of nivolumab when used in combination with ipilimumab and ...
Posted by Michael Wonder on 13 Jan 2021
CADTH publishes initial pCODR recommendation for entrectinib
9 January 2021 - pERC has conditionally recommended the reimbursement of entrectinib for the first-line treatment of patients with ROS1 positive ...
Posted by Michael Wonder on 29 Oct 2020
CADTH publishes final recommendation for Blincyto
29 October 2020 - The pERC final recommendation is based on a reconsideration of the initial recommendation and feedback from eligible ...
Posted by Michael Wonder on 29 Oct 2020
Sales of cancer fighting drugs soared in Canada over the past decade
29 October 2020 - Canada is the only country with a universal health care system without coverage for prescription drugs. ...
Posted by Michael Wonder on 05 Oct 2020
Radiopharmaceutical Lutathera now reimbursed in Quebec for cancer patients with advanced gastro-enteropancreatic neuroendocrine tumours
1 October 2020 - Lutathera is the first and only therapeutic radiopharmaceutical indicated in the treatment of GEP-NETs in Canada. ...
Posted by Michael Wonder on 08 Sep 2020
Roche Canada announces FoundationOne Liquid CDx now available in Canada
8 September 2020 - Comprehensive pan-tumour liquid biopsy test analyzes >300 cancer-associated genes and multiple genomic signatures to inform treatment choices. ...
Posted by Michael Wonder on 13 Aug 2020
Impact of rarity on Canadian oncology health technology assessment and funding
11 August 2020 - The pan-Canadian Oncology Drug Review evaluates new cancer drugs for public funding recommendations. ...
Posted by Michael Wonder on 18 May 2020
Montreal mother launches desperate plea for help to access experimental cancer treatment
17 May 2020 - Montreal mother launches desperate plea to access experimental cancer treatment in U.S. amid COVID-19 travel restrictions. ...